Table 1.
Combined | Males (52.6%) | Females (47.4%) | |||||||
---|---|---|---|---|---|---|---|---|---|
Trait | Deficient | Sufficient | p value* | Deficient | Sufficient | p value* | Deficient | Sufficient | p value* |
(<50nmol/L) | (≥50nmol/L) | (<50nmol/L) | (≥50nmol/L) | (<50nmol/L) | (≥50nmol/L) | ||||
Prevalence | (%) | (%) | (%) | (%) | (%) | (%) | |||
Total (n=1,765) | 75.8 | 24.2 | p<0.0001 | 78.3 | 21.7 | p<0.0001 | 72.6 | 27.4 | p<0.0001 |
Type 2 Diabetes | 83.51 | 16.5 | p<0.0001 | 85 | 15 | p<0.0001 | 81.6 | 18.4 | p<0.0001 |
Normoglycemic controls | 68.01 | 32.7 | p<0.0001 | 71.5 | 28.5 | p<0.0001 | 63.5 | 36.5 | p<0.0001 |
BMI<23kg/m2 | 65.22 | 34.8 | p<0.0001 | 68.7 | 31.3 | p<0.0001 | 59.8 | 40.2 | p=0.012 |
BMI 23–27.5kg/m2 | 75.52,3 | 24.5 | p<0.0001 | 80.2 | 19.8 | p<0.0001 | 68.6 | 31.4 | p<0.0001 |
BMI>27.5kg/m2 | 81.43 | 18.6 | p<0.0001 | 82.4 | 17.6 | p<0.0001 | 80.4 | 19.6 | p<0.0001 |
Hypertensive (>140/85) | 78.24 | 21.8 | p<0.0001 | 81.8 | 18.2 | p<0.0001 | 73.8 | 26.2 | p<0.0001 |
Non-Hypertensive | 72.84 | 27.2 | p<0.0001 | 74.1 | 25.9 | p<0.0001 | 71.6 | 28.4 | p<0.0001 |
β (95% CI) | p value | β (95% CI) | p valued | β (95% CI) | p valued | ||||
Type 2 Diabetes | −0.41 (−0.5, −0.3) | 2.8×10−20a | −0.5 (−0.6, −0.4) | 4.9×10−17 | −0.3 (−0.4, −0.2) | 3.6×10−7 | |||
Metabolic Traits | |||||||||
Fasting Glucose (mg/dL) | −0.18 (−0.3,−0.03) | 0.022b | −0.01 (−0.04, 0.01) | 0.31 | −0.03 (−0.5, −0.003) | 0.03 | |||
Fasting Insulin (µIU/mL) | 0.04 (−0.01, 0.09) | 0.145b | 0.006 (0.07, 0.08) | 0.89 | 0.08 (0.002, 0.2) | 0.044 | |||
C Peptide (ng/mL) | 0.09 (0.02,0.1) | 0.017b | 0.002 (0.1, 0.1) | 0.97 | 0.21 (0.09, 0.3) | 4.9×10−4 | |||
Amylin (pg/mL) | 0.019 (−0.002,0.04) | 0.071b | 0.004 (0.03, 0.03) | 0.82 | 0.04 (0.009, 0.06) | 0.009 | |||
HOMA-B | 0.17 (0.09,0.2) | 8.0×10−6b | 0.09 (0.001, 0.19) | 0.05 | 0.2 (0.1, 0.3) | 1.4×10−5 | |||
Obesity | |||||||||
BMI (kg/m2) | −0.71 (−0.9, −0.4) | 1.4×10−7c | −0.6 (−0.9, −0.3) | 3.8×10−4 | −0.8 (−1.2, −0.4) | 8.7×10−5 | |||
Cardiovascular Traits | |||||||||
Systolic BP (mmHg) | −1.68 (−2.9, −0.4) | 0.006b | −3.2 (-4.9, −1.5) | 1.8×10−4 | −1.0 (−2.9, 0.7) | 0.23 | |||
Diastolic BP (mmHg) | 0.32 (0.3,0.9) | 0.35b | 0.2 (1.2, 0.8) | 0.75 | 0.3 (0.6, 1.2) | 0.56 | |||
Pulse Pressure mmHg) | −1.85 (−2.8, −0.9) | 1.2×10−4b | −3.1 (−4.3, −1.8) | 2.3×10−6 | −1.0 (−2.4, 0.4) | 0.17 |
Prevalence *Chi-square analysis:
T2Dvs Normoglycemic (p<0.0001);
BMI<23 vs BMI 23–27.5 (p<0.0001);
BMI 23–27.5 vs BMI>27.5 (p<0.0001);
Hypertensive vs Non-Hypertensive (p<0.0001);
Multiple Regression a Logistic regression adjusted for BMI, age, gender;
Linear regression adjusted for T2D, age, BMI and gender;
Linear regression adjusted for T2D, age and gender;
Gender was excluded as co-variant